Paul Chang
InvestorAnalyst, Public Equity at Sofinnova Ventures
About
Paul Chang is an Analyst who joined Sofinnova BioEquities in 2025, where he works on public investments in medical technology and diagnostics. He previously served as an Investment Associate at TPG Growth, sourcing healthcare investments and supporting portfolio companies, and before that was an investment banker at Goldman Sachs covering healthcare M&A and financing. He holds a BS in Finance with a minor in English Literature from New York University.
Invests in
HealthtechMedical Devices
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures
Frequently asked questions
- Who is Paul Chang?
- Paul Chang is an Analyst who joined Sofinnova BioEquities in 2025, where he works on public investments in medical technology and diagnostics. He previously served as an Investment Associate at TPG Growth, sourcing healthcare investments and supporting portfolio companies, and before that was an investment banker at Goldman Sachs covering healthcare M&A and financing. He holds a BS in Finance with a minor in English Literature from New York University.
- Where does Paul Chang work?
- Paul Chang is Analyst, Public Equity at Sofinnova Ventures.
- What does Paul Chang invest in?
- Paul Chang invests in Healthtech, Medical Devices.